NxStage PureFlow-B Solution; Model/Catalog Number: RFP-401. Product is packaged in a case contai...
FDA Device Recall #Z-1073-2014 — Class II — January 24, 2014
Recall Summary
| Recall Number | Z-1073-2014 |
| Classification | Class II — Moderate risk |
| Date Initiated | January 24, 2014 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | NxStage Medical, Inc. |
| Location | Lawrence, MA |
| Product Type | Devices |
| Quantity | 969 cases (2 bags per case) |
Product Description
NxStage PureFlow-B Solution; Model/Catalog Number: RFP-401. Product is packaged in a case containing two individual 5L bags. The NxStage PureFlow-B Solution is indicated for use with renal replacement therapy systems that utilize sterile premixed dialysate during hemodialysis.
Reason for Recall
Mislabeled product.
Distribution Pattern
US Distribution including the states of NY, TX, ID, AR, CA and AL
Lot / Code Information
Lot Number: F113662
Other Recalls from NxStage Medical, Inc.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-0697-2020 | Class II | Low Volume Cartridge IFU (SKU CAR-125-B) used w... | Aug 27, 2019 |
| Z-1706-2019 | Class II | NxStage PureFlow B Solution, REF RFP-400, M535R... | Apr 11, 2019 |
| Z-1707-2019 | Class II | NxStage PureFlow B Solution, REF RFP-401, M535R... | Apr 11, 2019 |
| Z-0502-2019 | Class II | NxStage PureFlow B Solution-RFP-402, Premixed D... | Oct 17, 2018 |
| Z-0500-2019 | Class II | NxStage PureFlow B Solution-RFP-400, Premixed D... | Oct 17, 2018 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.